Environmental Engineering Reference
In-Depth Information
80. Sinz A, Bantscheff M, Mikkat S et al (2002) Mass spectrometric proteome analyses of
synovial fluids and plasmas from patients suffering from rheumatoid arthritis and comparison
to reactive arthritis or osteoarthritis. Electrophoresis 23:3445-3456
81. He QY, Lau GK, Zhou Y et al (2003) Serum biomarkers of hepatitis B virus infected liver
inflammation: a proteomic study. Proteomics 3:666-674
82. Tamilvanan S, Schmidt S, Muller RH, Simon B (2005) In vitro adsorption of plasma proteins
onto the surface (charges) modified-submicron emulsions for intravenous administration. Eur
J Pharm Biopharm 59:1-7
83. Shegokar R, Jansch M, Singh KK, M¨ ller RH (2011) In vitro protein adsorption studies on
nevirapine nanosuspensions for HIV/AIDS chemotherapy. Nanomed Nanotech Biol Med
7:333-340
84. Kasongo WK, Jansch M, Muller RH, Walker RB (2011) Evaluation of the in vitro differential
protein adsorption patterns of didanosine-loaded nanostructured lipid carriers (NLCs) for
potential targeting to the brain. J Liposome Res 21(3):245
85. Gref R, Luck M, Quellec P, Marchand M, Dellacherie E, Harnisch S, Blunk T, Muller RH
(2000)
'
Stealth
'
corona-core nanoparticles surface modified by polyethylene glycol (PEG):
influences of the corona (PEG chain length and surface density) and of the core composition
on phagocytic uptake and plasma protein adsorption. Colloids Surf B Biointerfaces 18:301-
313
86. Zhang H, Burnum KE et al (2011) Quantitative proteomics analysis of adsorbed plasma
proteins classifies nanoparticles with different surface properties and size. Proteomics
11:4569-4577
87. Kowalczyk B, Lagzi I, Grzybowski BA (2011) Nanoseparations: strategies for size and/or
shape-selective purification of nanoparticles. Curr Opin Coll Inter Sci 16:135-148
88. Nilsson CL (2002) Bacterial proteomics and vaccine development. Am J Pharmacogenomics
2(1):59-65
89. Humphery-Smith I, Cordwell SJ, Blackstock WP (1997) Proteome research: complementar-
ity and limitations with respect to the RNA and DNA worlds. Electrophoresis 18(8):1217-
1242
90. Clayton RA, White O, Fraser CM (1998) Findings emerging from complete microbial
genome sequences. Curr Opin Microbiol 1(5):562-566
91. Adamczyk-Poplawska M, Sergiusz Markowicz S, Jagusztyn-Krynick EK (2011) Proteomics
for development of vaccine. J Proteom 74:2596-2616
92. Cai X, Ramalingam R et al (2013) Characterization of carbon nanotube protein corona by
using quantitative proteomics. Nanomed Nanotech Biol Med 9:583-593
93. Wang X, Jia G, Wang H, Nie H, Yan L, Deng XY et al (2009) Diameter effects on
cytotoxicity of multi-walled carbon nanotubes. J Nanosci Nanotechnol 9:3025-3033
94. Ge C, Du J, Zhao L, Wang L, Liu Y, Li D et al (2011) Binding of blood proteins to carbon
nanotubes reduce cytotoxicity. Proc Natl Acad Sci U S A 108(41):16968-16973
95. Kussmann M, Panchaud A, Affolter M (2010) Proteomics in nutrition: status quo and outlook
for biomarkers and bioactives. J Proteome Res 9:4876-4887
96. Cairns DA (2011) Statistical issues in quality control of proteomic analyses: good experi-
mental design and planning. Proteomics 11:1037-1048
97. Gaso-Soka
ˇ
D, Kova
ˇ
S, Josi
´
D (2010) Application of proteomics in food technology and
food biotechnology: process development, quality control and product safety. Food Technol
Biotechnol 48:284-295
98. Rinalducci S, D
'
Amici GM, Blasi B, Vaglio S, Grazzini G, Zolla L (2011) Peroxiredoxin-2 as
a candidate biomarker to test oxidative stress levels of stored red blood cells under blood bank
conditions. Transfusion 51:1439-1449
99. Minkiewicz P, Dziuba J, Iwaniak A, Dziuba M, Darewicz M (2008) BIOPEP database and
other programs for processing bioactive peptide sequences. J AOAC Int 91:965-980
100. Mouat MF, Kolli K, Orlando R, Hargrove JL, Grider A (2005) The effects of quercetin on
SW480 human colon carcinoma cells: a proteomic study. Nutr J 4:11
